EEOICPA BULLETIN NO.02-08
________________________________________________________________
________________________________________________________________
________________________________________________________________
Subject:
Clarification of the onset period for specified cancers and the 250-day
employment requirement at a Gaseous Diffusion Plant.
Background:
Issues have arisen as to how exposure to ionizing radiation at a Gaseous
Diffusion Plant (GDP) should be determined with respect to: (1) the 250-day GDP
employment requirement and (2) the time period between first radiation exposure
at a GDP and diagnosis of a specified cancer.
Regarding the
first issue, for inclusion in the Special Exposure Cohort (SEC), the employee
must have been employed for an aggregate of at least 250 workdays before
February 1, 1992, at a GDP located in Paducah, KY, Portsmouth, OH, or Oak
Ridge, TN (per EEOICPA Section 7384l(14)). The employee may accumulate the days of
service at more than one GDP to satisfy the 250 workday requirement (per 20 CFR
30.213(b)).
The second
issue addresses the length of time following first exposure to radiation at a
GDP until the diagnosis of the employees’ specified cancer. EEOICPA
Section 7384l(17) defines specified cancers for inclusion in the
SEC. The Act also states that certain
onset time requirements need to be met in order to qualify for SEC
inclusion. For most cancers, an eligible
employee must have developed a specified cancer 5 years after first
exposure. In the case of leukemia, an
onset time of more than two years after initial occupational exposure is
required. There are no delay of onset periods for primary or secondary lung,
bone, and renal cancers.
Reference: Energy Employees Occupational Illness
Compensation Program Act of 2000, As Amended, 42 U.S.C. § 7384 et seq., Sections 7384l (14) and (17)
and 20 CFR 30.213(b).
Purpose:
To clarify the onset period for specified cancers and the 250-day
employment requirements for workers at a GDP.
Applicability: All staff.
Actions:
1.
For
inclusion in the SEC the CE must first determine that the employee was employed
for an aggregate of at least 250 workdays before February 1, 1992, at a GDP
located in Paducah, KY, Portsmouth, OH, or Oak Ridge, TN (per EEOICPA Section 7384l(14)). The individual may be employed at more than
one GDP to satisfy the 250 workday requirement (per 20 CFR 30.213(b)).
2.
Additional
information for the CE to consider involves when the radiation monitoring
requirements in EEOICPA Section 7384l(17)(A)(i)
and (ii) should be applied. During the
construction period at the GDPs, the dosimetry badging requirements generally
do not apply since radioactive material was not present on the site. Once radioactive material (uranium) was on
site for enrichment, the dosimetry badging or comparable exposure aspects of Section 7384l(17)(A)(i) and (ii) would
apply.
3.
Next,
the CE must address the second criterion, which relates to the determination of
the time of onset of a specified cancer after initial exposure to radiation at
a GDP. The first day of employment at
any of the three GDPs “starts the clock” for determining the time of onset of a
specified cancer, i.e., it is the first day of exposure. The date of diagnosis “stops the clock” and
must meet the requirements for the time of onset for the specified cancer
stated in EEOICPA Section 7384l(17)
(the periods are discussed further below).
4.
A
number of specified cancers are listed in the Act. For these specified cancers, the CE must
determine that the date of diagnosis is at least 5 years after first exposure
at a GDP (per EEOICPA Section 7384l(17)).
There are no delay of onsets for primary or secondary lung, bone, and renal
cancers.
5.
For
leukemia, the CE must determine that the date of diagnosis is greater than two
years after initial occupational exposure at the GDP (per EEOICPA Section 7384l(17)).
6.
The CE should consider the following
example in assessing GDP employment using the above criteria. In this example, an employee started at a
K-25 (a GDP site) and worked 1 year before leaving to work at Y-12 (non-GDP
site). After working at Y-12 for 4.5
years, he was diagnosed with a specified cancer. Since he accumulated over 250 aggregate
workdays of GDP employment and the cancer was diagnosed 5 years after first
exposure at the GDP, he is eligible as a member of the SEC.
7.
Another example that the CE should
consider in making determinations regarding the above criteria involves the
following situation. In this example, an
employee started at Y-12 (a non-GDP site), worked for 4.5 years, and then spent
1 year at K-25 (a GDP site). A specified
cancer was diagnosed after only one year at K-25. In this case, while the employee has
accumulated over 250 aggregate workdays of GDP employment it has not been 5
years between first exposure at K-25 and cancer diagnosis. Consequently, the employee would not yet be
eligible as a member of the SEC.
8.
If the employee
worked at a GDP but does not qualify as a member of the SEC, e.g., has a
non-specified cancer, the case needs to go to NIOSH for dose reconstruction.
Disposition:
Retain until incorporated in the Federal (EEOICPA) Procedure Manual
PETER
M. TURCIC
Occupational
Illness Compensation